Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa. This category includes… Read more




























![Chemical structure of Fluoxetine Related Compound C (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxo (1279837)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FFluoxetine-Related-Compound-C-4-methyl3-phenyl-3-4-trifluoromethylphenoxypropylamino-4-oxo-1279837.png&w=3840&q=75)

















Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa. This category includes essential reference standards for fluoxetine, covering its pharmacopeial and non-pharmacopeial impurities, primary metabolites such as norfluoxetine, and various stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for rigorous analytical testing and quality control throughout the drug development lifecycle. These compounds are critical for effective impurity profiling, allowing researchers to detect, identify, and quantify both degradation products and process-related impurities in compliance with regulatory guidelines. Furthermore, stable isotope labelled standards serve as reliable internal markers in mass spectrometry to ensure precise measurement and method validation. By providing consistently characterized materials, this collection supports the maintenance of stringent quality standards in pharmaceutical research and manufacturing, ensuring the safety and efficacy of the final therapeutic product.